Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.68
+0.17 (2.26%)
Sep 5, 2025, 12:38 PM - Market open
Evolus Market Cap
Evolus has a market cap or net worth of $496.78 million as of September 5, 2025. Its market cap has decreased by -46.44% in one year.
Market Cap
496.78M
Enterprise Value
590.60M
1-Year Change
-46.44%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $496.78M, an increase of 83.10%. That is a compound annual growth rate of 8.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 485.79M | -30.51% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |